Corrigendum: Efficacy and Safety of CAR-T Cell Products Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel for the Treatment of Hematologic Malignancies: A Systematic Review and Meta-Analysis

• Jun Meng,
• XiaoQin Wu,
• Zhen Sun,
• RenDe Xun,
• MengSi Liu,
• Rui Hu,
• JianChao Huang

Affiliations

Jun Meng

Molecular Genetics Laboratory, Suining Central Hospital, Suining, China

XiaoQin Wu

Department of Neurosurgery, The First Affiliated Hospital, University of South China, Hengyang, China

Zhen Sun

Hengyang Medical College, University of South China, Hengyang, China

RenDe Xun

Department of Neurosurgery, The First Affiliated Hospital, University of South China, Hengyang, China

MengSi Liu

Hengyang Medical College, University of South China, Hengyang, China

Rui Hu

Hengyang Medical College, University of South China, Hengyang, China

JianChao Huang

Department of Neurosurgery, The First Affiliated Hospital, University of South China, Hengyang, China